Efficacy of the Early Prone-positioning in Hospitalized Patients With Mild Covid-19 Pneumonia (EpCOT)
Open-label, Controlled, Randomized Clinical Trial on the Efficacy of Early Prone-positioning in Patients With Mild Pneumonia Due to SARS-CoV-2
Sponsor: University of Milano Bicocca
This NA trial investigates COVID-19 Pneumonia and is currently completed. University of Milano Bicocca leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Study Description(click to expand)In this prospective, unicentred, open, controlled study, patients will be randomized on a 1:1 ratio using casual permutation blocks, identifying two branches of treatment: standard of care; standard of care + prone positioning. Patients will be stratified in 4 strata based on the onset of symptoms (\<10 days; \>10 days) and need of oxygen therapy (no need; need). In order to obtain statistical significance, the sample size will include 96 patients. Patients in the SOC + prone-positioning branch will undergo cycles of prone-positioning following this scheme: 3-6 hours of prone-positioning twice a day. The actual length of the cycles will be registered during the study. Data will be collected using a dedicated CRF, which will include recording of adverse events and concurrent medications. Patients will be evaluated on the day of the enrolment, on day 1, day 3, day 7 and every 7 days until the patient dismissal or until day 28 (whichever occurs first). If dismissal occurs before day 28, a follow-up interview will be conducted in presence or on the phone to collect the remaining data. The analysis will be conducted according to "intention to treat" criteria; primary outcomes will be calculated using survival-based methods (Kaplan-Meier curves with...
In this prospective, unicentred, open, controlled study, patients will be randomized on a 1:1 ratio using casual permutation blocks, identifying two branches of treatment: standard of care; standard of care + prone positioning. Patients will be stratified in 4 strata based on the onset of symptoms (\<10 days; \>10 days) and need of oxygen therapy (no need; need).
In order to obtain statistical significance, the sample size will include 96 patients.
Patients in the SOC + prone-positioning branch will undergo cycles of prone-positioning following this scheme: 3-6 hours of prone-positioning twice a day. The actual length of the cycles will be registered during the study.
Data will be collected using a dedicated CRF, which will include recording of adverse events and concurrent medications.
Patients will be evaluated on the day of the enrolment, on day 1, day 3, day 7 and every 7 days until the patient dismissal or until day 28 (whichever occurs first). If dismissal occurs before day 28, a follow-up interview will be conducted in presence or on the phone to collect the remaining data.
The analysis will be conducted according to "intention to treat" criteria; primary outcomes will be calculated using survival-based methods (Kaplan-Meier curves with log-rank test and Cox regression), while secondary outcomes will be evaluated using both survival-based methods and proportional odds model.
The occurrence of adverse events and the causes of withdrawal from the study in the two branches of treatment will be compared using chi-square test.
Status Flow
Change History
5 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2021 — Dec 2022 [monthly]
Recruiting NA
First recorded
Aug 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Milano Bicocca
For direct contact, visit the study record on ClinicalTrials.gov .